Global Cerebral Vasospasm Drugs and Companies Pipeline Review H1 2017

Cerebral Vasospasm Therapeutic and Drug Pipeline Review H1

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ — Summary
Cerebral Vasospasm Global Clinical Trials Review, H2, 2016" provides an overview of Cerebral Vasospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Vasospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/644189-cerebral-vasospasm-global-clinical-trials-review-h2-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cerebral Vasospasm to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Cerebral Vasospasm Therapeutics Clinical Trials 28
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/644189-cerebral-vasospasm-global-clinical-trials-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Merck more than a Mother Media Recognition Awards-Call for Applications

Merck More Than a Mother with Grace Kambini AKA “Mama Chips”

Merck More Than a Mother with Elishiba Njoki

Merck More Than a Mother with Byansi Adrian Ssemugga and Sawuya Ntongo, couple from Uganda

NAIROBI, KENYA, June 14, 2017 /EINPresswire.com/ — "We have established this award to showcase and appreciate outstanding health journalism and to recognize individual professional journalists and students who have produced accurate, informative, and compelling stories about infertile women or couples," emphasized Dr. Rasha Kelej, Chief Social Officer of Merck Healthcare and President of “Merck More than a Mother”. 

The stories targeted are those of infertile women sharing their suffering and abuse by their husbands, families or communities due to their condition. It is very critical to share these stories with the public to build advocacy of the need to change such behavior and break the stigma around infertility in general. It also will provide a platform for those who have sought treatment to advise others on the journey and support those undergoing infertility treatments.

The stories submitted should be in a form of articles with photos, or three to five-minute videos recorded using smart devices.

Visit our website to see examples of the videos and different articles about infertile women, men and couples. www.merckmorethanamother.com

The Awards will honor and reward outstanding journalistic coverage that enhances the public’s engagement and understanding of infertility stigma and the need to change the social perception of it in African communities.

Watch videos below on the stories of women’s suffering as a result of the infertility stigma.

Merck More Than a Mother with Grace Kambini AKA "Mama Chips"
Merck More Than a Mother with Elishiba Njoki
Merck More Than a Mother with Byansi Ssemugga and Sawuya Ntongo, couple from Uganda

Prize Award

Category Journalists Student

Multimedia USD 5000 USD 3000

Print USD 1500 USD 1000

Radio USD 1500 USD 1000

Online USD 1500 USD 1000

Who can apply?

The Award is open to print, video broadcast, photojournalists and media students whose stories appear in newspapers, websites, blogs and television and that target the public.

Categories

Submission will be judged and recipients selected based on the following categories:

Print and Online

-Newspapers or magazines

-Online (blogs and/or social media)

Broadcast

-Television

-Online (blogs and /or social media)

Photos

-Newspaper or magazines

-Online(blogs and /or social media)

Judging Panel

The judging panel consists of experts from diverse professional backgrounds including journalists, communications experts, and media managers.

Eligibility

-The story must have been published any time before 30th  AUGUST 2017

-Links to the stories must be submitted before the deadline.

-Plagiarism of any kind will lead to automatic disqualification

-Photo entries will only be limited to 2 photographs per journalist/student.

-Applicants should be East African journalists and registered media students in East Africa.

Deadline

Deadline for submission of the stories and photos is 31st AUGUST 2017.

Application Process

Applicants Name, Sex, Age, Media House or Institution (for students), Country and Contacts must be provided with the submission.

Applications can be submitted via: mystory@merckmorethanamother.com

Health and Social Facts

Inability to have a child or to conceive can result in being greatly ostracized, isolated, disinherited or assaulted. This may lead to denial of access to family traditions, divorce or physical and psychological abuse. The social stigma of childlessness especially for infertile women still leads to isolation and stigmatization in many cultures. While it’s estimated that about 50% of infertility cases are caused by male factors, women are left to solely carry the burden of blame.

Together we can create a Culture Shift.

"Merck More than a Mother" Campaign is very important for Africa, as it is well known that the consequences of infertility are much more dramatic in developing countries and can create more wide-ranging social and cultural problems compared to western societies, particularly for women.
"Merck More than a Mother" Campaign aims to empower infertile women through access to information, health, change of mindset and economic empowerment.

The Awards

The Merck More than a Mother Media Recognition Awards is an initiative by Merck, the world’s oldest pharmaceutical and chemical company; to raise awareness about the critical role the media can play in breaking the stigma around infertility. It also aims to change the culture of discrimination and abuse of infertile women while educating the public about infertility prevention, management, and male infertility. In addition, the campaign aims to encourage men to discuss their infertility condition openly, support their wives through the journey of testing and treatment.
Fertility is a Shared Responsibility.

About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Lizbeth Kariuki
+254787319395
email us here
LiNK PR Kenya


Source: EIN Presswire

Acute Kidney Injury Therapeutic and Drug Pipeline Review H1

Acute Kidney Injury Pharmaceutical and Healthcare Pipeline Review H1

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ — Summary
“Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1164560-acute-renal-failure-arf-acute-kidney-injury-global-clinical-trials-review-h1-2017

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1164560-acute-renal-failure-arf-acute-kidney-injury-global-clinical-trials-review-h1-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

China Spinal Surgery Therapeutic and Drug Pipeline Review H1

China Spinal Surgery Pharmaceutical and Healthcare Pipeline Review H1

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ — Summary
"China Spinal Surgery Market Outlook to 2021", provides key market data on the China Spinal Surgery market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments – Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/247417-china-spinal-surgery-market-outlook-to-2021

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. Research uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
– Market size for Spinal Surgery market categories – Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices.
– Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
– 2014 company shares and distribution shares data for Spinal Surgery market.
– Global corporate-level profiles of key companies operating within the China Spinal Surgery market.
– Key players covered include Medtronic, Inc., DePuy Companies, Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Orthofix International N.V., Zimmer Holdings, Inc., Biomet, Inc., Alphatec Holdings, Inc. and K2M, Inc.

Reasons to buy
– Develop business strategies by identifying the key market segments poised for strong growth in the future.
– Develop market-entry and market expansion strategies.
– Design competition strategies by identifying who-stands-where in the market.
– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
– What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Content: Key Points

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Spinal Surgery Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Spinal Surgery Market, China 11
3.1 Spinal Surgery Market, China, Revenue ($m), 2007-2014 11
3.2 Spinal Surgery Market, China, Revenue ($m), 2014-2021 13
3.2.1 Minimal Invasive Spinal Devices Market, China, Revenue ($m), by Segment, 2007-2014 15
3.2.2 Spinal Fusion Market, China, Revenue ($m), by Segment, 2007-2014 17
3.2.3 Spinal Non-Fusion Market, China, Revenue ($m), by Segment, 2007-2014 19
3.2.4 Vertebral Body Replacement Systems Market, China, Revenue ($m), by Segment, 2007-2014 21
3.2.5 Vertebral Compression Fracture Repair Devices Market, China, Revenue ($m), by Segment, 2007-2014 23
3.2.6 Minimal Invasive Spinal Devices Market, China, Revenue ($m), by Segment, 2014-2021 25
3.2.7 Spinal Fusion Market, China, Revenue ($m), by Segment, 2014-2021 27
3.2.8 Spinal Non-Fusion Market, China, Revenue ($m), by Segment, 2014-2021 29
3.2.9 Vertebral Body Replacement Systems Market, China, Revenue ($m), by Segment, 2014-2021 31
3.2.10 Vertebral Compression Fracture Repair Devices Market, China, Revenue ($m), by Segment, 2014-2021 33
3.3 Spinal Surgery Market, China, Volume (Units), 2007-2014 35
3.4 Spinal Surgery Market, China, Volume (Units), 2014-2021 37
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/247417-china-spinal-surgery-market-outlook-to-2021

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Gel Documentation Systems 2017 Global Market Expected to Grow at CAGR Of 6.93% and Forecast to 2021

Wiseguyreports.Com Publish New Market Research Report On-“Gel Documentation Systems 2017 Global Market Expected to Grow at CAGR Of 6.93% and Forecast to 2021”.

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ —

Gel Documentation Systems Market 2017

About Gel Documentation Systems
Gel documentation systems or gel imaging systems could be defined as a package of instruments used to record and measure nucleic acid and protein in various types of media such as cellulose, acrylamide, and agarose. These systems come in a variety of configurations depending on the desired application and sample type. A typical gel documentation system consists of a camera with lenses of variable detection power, imaging filters, overhead illuminator, passage of light, which illuminates the gel placed on an adjustable stage and an additional transilluminator which enables collection of light. Through the use of chemiluminescence and fluorescence, gel documentation systems are deployed for various applications is hospitals, diagnostic centers, and research institutions.

The analysts forecast the global gel documentation systems market to grow at a CAGR of 6.93% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global gel documentation systems market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of gel documentation systems to the various end-users discussed in this report.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1408423-global-gel-documentation-systems-market-2017-2021

The report, Global Gel Documentation Systems Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Bio-Rad
• GE Healthcare
• Thermo Fisher Scientific

Other prominent vendors
• Analytik Jena
• Cleaver Scientific
• Corning
• eikonix
• Gel Company
• Syngene
• TBG Diagnostics
• VWR International

Market driver
• Increase in use of molecular biology techniques in clinical practice
• For a full, detailed list, view our report

Market challenge
• Lack of efficiency and effectiveness compared to conventional methods
• For a full, detailed list, view our report

Market trend
• Rising costs of clinical trials
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/1408423-global-gel-documentation-systems-market-2017-2021

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by end-user
• Market overview
• Hospitals and diagnostic centers
• Pharma and biotech companies
• Academic and research institutes

PART 07: Geographical segmentation
• Market Overview
• Americas
• EMEA
• APAC

PART 08: Decision framework

PART 09: Drivers and challenges
• Market drivers
• Market challenges

PART 10: Market trends
• Rising costs of clinical trials
• Increasing patient awareness on the importance of early diagnosis
• Emergence of low cost Chinese gel doc systems
..…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1408423

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Tennessee Mesothelioma Victims Center Now Appeals to A Navy Veteran with Mesothelioma in Tennessee To Call Them for Instant Access to Some of The Nation's Top Compensation Lawyers

We are appealing to a US Navy Veteran diagnosed with mesothelioma in Tennessee to please call us at 800-714-0303 for instant access to some of the nation's most skilled mesothelioma attorneys”

— Tennessee Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, June 14, 2017 /EINPresswire.com/ — The Tennessee Mesothelioma Victims Center says, "We are appealing to a US Navy Veteran who has recently been diagnosed with mesothelioma in Tennessee or their family to please call us at 800-714-0303 for instant access to some of the nation's most skilled, and experienced mesothelioma attorneys. If you are a Navy Veteran with mesothelioma who want's the best possible financial compensation it is vital you hire the nation's most capable mesothelioma attorneys.

"The attorneys we suggest can answer every imaginable question about how the mesothelioma compensation claims process works, and because they are so experienced they should be able to provide the Navy Veteran with a no obligation financial claims evaluation. We are confident that once a Navy Veteran or their family members talk to the mesothelioma attorneys we suggest they will know they are talking to mesothelioma compensation experts as well as extremely talented trial attorneys. We also want to emphasize the mesothelioma attorneys we suggest are extremely knowledgeable and they sell themselves when it comes to Navy Veterans with mesothelioma." http://Tennessee.MesotheliomaVictimsCenter.Com

In all likelihood-a US Navy Veteran with mesothelioma in Tennessee was probably exposed to asbestos at a US Navy Base or shipyard in Virginia, California, Connecticut, Washington, Georgia, Maine, Hawaii, Subic Bay, or Okinawa.

If the Tennessee Mesothelioma Victims Center had one vital tip for a US Navy Veteran in Tennessee or their family it would be call them first at 800-714-0303 before they hire a lawyer or law firm to assist with a compensation claim. As they would like to discuss-"Once you hire a lawyer/law firm to assist with a mesothelioma compensation claim you are stuck with them-if they are inexperienced or unskilled. We want US Navy Veterans with mesothelioma to receive the best possible financial compensation-we do not want them to get shortchanged." http://Tennessee.MesotheliomaVictimsCenter.Com

The Tennessee Mesothelioma Victims Center wants to emphasize their free services are available statewide in every community in Tennessee, including Memphis, Nashville, Knoxville, Chattanooga, and Clarksville. http://Tennessee.MesotheliomaVictimsCenter.Com

The Tennessee Mesothelioma Victims Center is also very focused on making certain a diagnosed victim of mesothelioma has access to the best treatment option facilities in their state. For the best possible treatment options for mesothelioma in Tennessee, the Tennessee Mesothelioma Victims Center strongly encourages diagnosed victims, or their family to consider:
* The Vanderbilt-Ingram Cancer Center, Nashville: http://www.vicc.org/dd/dz/results.php?name=malignant-mesothelioma
* Baptist Memorial Hospital in Memphis: http://www.baptistonline.org/memphis/

The average age for a diagnosed victim of mesothelioma is about 70 years old. Frequently victims of mesothelioma are initially misdiagnosed with pneumonia. This year between 2,500 and 3,000 US citizens will be diagnosed with mesothelioma.

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. Mesothelioma also happens in Tennessee.

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: http://www.nlm.nih.gov/medlineplus/mesothelioma.html

Michael Thomas
Tennessee Mesothelioma Victims Center
800-714-0303
email us here


Source: EIN Presswire

Blood Clot Retrieval Devices 2017 Global Market Expected to Grow at CAGR 6.58% and Forecast to 2021


The analysts forecast the global blood clot retrieval devices market to grow at a CAGR of 6.58% during the period 2017-2021.

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ —

Global Blood Clot Retrieval Devices Market

Description

The blood clot retrieval devices are used for endovascular revascularization, which is caused due to stroke. The clot retrieval process is performed within eight hours of the onset of stroke symptoms; the whole process of blood clot retrieval takes about two hours. Due to technological advances, the combination of intra-arterial thrombolysis and ultrasound are used to disrupt the clot and treat the individual with any ischemic stroke.

Covered in this report
The report covers the present scenario and the growth prospects of the global blood clot retrieval devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales, volume, and value of blood clot retrieval devices.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/1408362-global-blood-clot-retrieval-devices-market-2017-2021

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

The Global Blood Clot Retrieval Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Argon Medical Devices
• Boston Scientific
• Medtronic

Other prominent vendors
• Abbott
• Acandis
• AngioDynamics
• B. Braun
• Biosensors International
• Biotronik
• CONMED
• Cordis
• EKOS (BTG International)
• ENDOCOR
• ENDO-FLEX
• JOTEC
• Meril Life Sciences
• Neuravi
• NexGen Medical Systems
• OrbusNeich
• perflow
• Rontis
• STENTYS
• Stryker
• Teleflex

Market driver
• Increasing market entrants by launching new products
• For a full, detailed list, view our report

Market challenge
• Unfavorable results of futile recanalization procedures
• For a full, detailed list, view our report

Market trend
• Strategic acquisition of business segments
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/1408362-global-blood-clot-retrieval-devices-market-2017-2021

Table of Contents -Major Key Points

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Market overview
• Mechanical embolus removal devices
• Stent retrievers
• Ultrasound-assisted devices

PART 07: Market segmentation by end-user
• Market overview
• Hospitals and specialty clinics
• ASCs

PART 08: Geographical segmentation
• Market overview
• Blood clot retrieval devices market in Americas
• Blood clot retrieval devices market in EMEA
• Blood clot retrieval devices market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Strategic acquisition of business segments
• Paradigm shift toward minimally invasive procedures

PART 12: Vendor landscape
• Competitive analysis

PART 13: Key vendor analysis
• Argon Medical Devices
• Boston Scientific
• Medtronic
• Key companies to watch
• Other prominent vendors

………..CONTINUED

Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1408362

CONTACT US :

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industryresearch reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Dry Eye Syndrome (DES) Therapeutic and Drug Pipeline Review H1

Global Dry Eye Syndrome (DES) Drugs and Companies Pipeline Review H1 2017

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ — Summary
Dry Eye Syndrome (DES), also known as keratoconjunctivitis sicca, is a multifactorial disease of the tears and ocular surface. This ocular condition can cause ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and Mucosta in 2010 and 2013, respectively. However, the lack of treatment options is about to change with the expected launch of numerous pipeline DES drugs during the forecast period, which will be a significant driver of growth in the 9MM. Indeed, this change has already been initiated with Ikervis’ recent arrival in Europe in 2015. Furthermore, additional marketing approvals are being sought for currently marketed DES drugs, Restasis and Diquas, in new countries in the 9MM, which will provide a source of growth in this market.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/607117-dry-eye-syndrome-us-drug-forecast-and-market-analysis-to-2024

Research estimates that DES drug sales in the US reached $1.3 billion during 2014, making it the largest market within the 9MM. After an initial period of minimal growth, Research estimates that the DES market will undergo a period of steady growth from 2016 and beyond, but this growth will begin to wane slightly towards the end of the forecast period. This growth is mainly attributed to the expected introduction of the highly anticipated pipeline DES drug, lifitegrast in late 2016, and additional pipeline products in 2018. This expansion of treatment options for DES patients will have the added effect of increasing overall treatment rates in the US.

Scope
– Overview of DES including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
– Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.
– Sales forecast for the top drugs in the US from 2014-2024.
– Analysis of the impact of key events as well the drivers and restraints affecting the US DES market.

Reasons to buy
– Understand and capitalize by identifying products that are most likely to ensure a robust return
– Stay ahead of the competition by understanding the changing competitive landscape for DES.
– Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
– Make more informed business decisions from insightful and in-depth analysis of drug performance
– Obtain sales forecast for drugs from 2014-2024 in US.

Table of Content: Key Points
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Related Reports 9
3 Disease Overview 11
3.1 Etiology and Pathophysiology 11
3.1.1 Etiology 11
3.1.2 Pathophysiology 14
3.2 Disease Classification 16
3.3 Symptoms 17
3.4 Prognosis 20
3.5 Quality of Life 21
4 Disease Management 22
4.1 Diagnosis and Treatment Overview 22
4.1.1 Diagnosis 22
4.1.2 Treatment Guidelines 25
4.1.3 Clinical Practice 26
4.2 US 32
5 Competitive Assessment 37
5.1 Overview 37
5.2 Product Profiles 38
5.2.1 Restasis (cyclosporine) 38
5.2.2 Diquas (diquafosol tetrasodium) 48
5.2.3 Mucosta ophthalmic solution (rebamipide) 54
5.2.4 Ikervis (cyclosporine) 59
5.2.5 Artificial Tears 66
5.2.6 Other therapies 74
6 Unmet Need and Opportunity 79
6.1 Overview 79
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/607117-dry-eye-syndrome-us-drug-forecast-and-market-analysis-to-2024

Contact Info:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Lupus Therapeutic Global Market Key Vendors – GlaxoSmithKline ,Medlmmune ,Pfizer and Forecast to 2021

The analysts forecast the global lupus therapeutic market to grow at a CAGR of 9.74% during the period 2017-2021.

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ —

Global Lupus Therapeutic Market

Description

Lupus is a chronic autoimmune disease in which the body's immune system becomes hyperactive and attacks normal, healthy tissue. This results in symptoms such as inflammation, swelling, and damage to joints, skin, kidneys, blood, the heart, and lungs. Systemic lupus erythematosus (SLE) is a major disease, which is followed by lupus nephritis at the later stages. Only one drug is approved specifically for the treatment of lupus disorders and the majority of other drugs are off-label based on symptoms. Due to a strong pipeline, the market is expected for more approved drugs for lupus disorders in future.

Covered in this report
The report covers the present scenario and the growth prospects of the global lupus therapeutic market for 2017-2021. To calculate the market size, the report considers both generic and branded drug market.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/1408371-global-lupus-therapeutic-market-2017-2021

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

The Global Lupus Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• F.Hoffmann-La Roche
• GlaxoSmithKline
• Medlmmune
• Pfizer

Other prominent vendors
• ADMA Biologics
• Amgen
• Anthera Pharmaceuticals
• Bayer HealthCare
• Biogen
• Biotest
• Bristol-Myers Squibb
• Celgene
• Immunomedics
• Kedrion Biopharma
• LFB Group
• Merck
• Novartis
• Shire
• Takeda Pharmaceuticals
• UCB

Market driver
• High prevalence rate
• For a full, detailed list, view our report

Market challenge
• Complexity of disease
• For a full, detailed list, view our report

Market trend
• Regenerative therapeutic technologies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/1408371-global-lupus-therapeutic-market-2017-2021

Table of Contents -Major Key Points

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: An overview of lupus disease

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Pipeline landscape

PART 08: Market segmentation by drug class
• Anti-inflammatory drugs
• Corticosteroids
• Immunosuppressant drugs
• Antimalarial drugs
• BLyS-specific inhibitors
• Biologicals
• Others

PART 09: Geographical segmentation
• Lupus therapeutics market in Americas
• Lupus therapeutics market in EMEA
• Lupus therapeutics market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Regenerative therapeutic technologies
• Inorganic growth strategies
• Government initiatives

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• F. Hoffmann-La Roche
• GlaxoSmithKline
• MedImmune
• Pfizer
• Other prominent vendors

………..CONTINUED

Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1408371

CONTACT US :

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industryresearch reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Spa Market 2017 Global Industry Analysis, Opportunities, Size, Trends, Growth and Forecast 2021

Wiseguyreports.Com Publish New Market Research Report On-“Spa Market 2017 Global Industry Analysis, Opportunities, Size, Trends, Growth and Forecast 2021”.

PUNE, INDIA, June 14, 2017 /EINPresswire.com/ —

Spa Market 2017

About Spa
A spa is a place where different treatments and facilities are provided for health and wellness. It is a popular destination for health management and body relaxation. Services such as massages, facials, salon services, hair spa, and other treatments are provided at a spa. It also offers fitness activities like yoga, Ayurveda medicines, and other medical treatments.

The analysts forecast the global spa market to grow at a CAGR of 5.66% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global spa market for 2017-2021. To calculate the market size, the report considers the spa service revenue generated from each ticket purchase on spa visits.

The market is divided into the following segments based on geography:
• APAC
• Europe
• North America
• ROW

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1408483-global-spa-market-2017-2021

The report, Global Spa Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• HOT SPRINGS RESORT & SPA
• Lanserhof
• Marriott International
• Massage Envy Franchising
• Rancho La Puerta

Other prominent vendors
• Aspira Spa
• Canyon Ranch
• Cal-a-Vie Health Spa
• Clinique La Prairie
• KEMPINSKI HOTELS
• The Mineral Spa
• The Clarins group
• Reflections Medical Spa
• THE WOODHOUSE Day Spa
• Young Medical Spa

Market driver
• Brand positioning enabling premium pricing
• For a full, detailed list, view our report

Market challenge
• Competition from beauty salons
• For a full, detailed list, view our report

Market trend
• Personalization of products and services
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/1408483-global-spa-market-2017-2021

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by type
• Market segmentation by type
• Day/club/salon spa
• Hotel/resort spa
• Medical spa
• Destination spa
• Thermal/mineral spring spa

PART 07: Geographical segmentation
• Geographical segmentation
• Spa market in Europe
• Spa market in APAC
• Spa market in North America
• Spa market in ROW

PART 08: Key leading countries
PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Personalization of products and services
• Increasing demand for natural and organic procedures
• Flotation therapy
• Fitness and yoga in spa facilities
..…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1408483

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire